NSEAcquisition25 Jun 2026 · 25 Jun 2026, 06:41 pm

Acquisition

Aurobindo Pharma Limited · AUROPHARMA

✦ AI Summaryacquisition

Aurobindo Pharma Limited has informed the Exchange about the completion of the execution of a solar power purchase agreement and acquired a 26% stake in Swarnaakshu Solar Power Private Limited.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aurobindo Pharma Limited has informed the Exchange about Acquisition

Attachments (1)

📄

AUROPHARMA_25062026184115_LtrToSEsUpdateSwarnakshu25062026.pdf

pdf

Download →
View document text
June 25, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Completion of execution of solar power purchase agreement and acquired 26% stake in Swarnaakshu Solar Power Private Limited. Ref : Our letters dated February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, December 30, 2025 and March 30, 2026. This has reference to aforementioned letters whereby Company informed about the execution of power purchase agreement with Swarnaakshu Solar Power Private Limited (Swarnaakshu), for purchase of solar power under the captive power policy of the Government of Telangana and investment up to Rs.10.40 crores for acquiring 26% of the paid up equity share capital and other securities of Swarnaakshu. In this regard, this is to inform that the Company has today i.e., June 25, 2026, made the initial investment of Rs. 52 lakhs and acquired 26% equity share capital of Swarnaakshu and also entered into a power purchase agreement with Swarnaakshu to purchase solar power for captive consumption. The balance investment will be made from time to time depending upon the progress of the solar project and fund requirements of Swarnaakshu. Please take the information on record. Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com